Blessie Elizabeth Nelson

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications”.

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0090

N/A

1.9DataRank · unranked

60 citations

Blessie Elizabeth Nelson, Lars Buschhorn, Adam Wahida, Vivek Subbiah, Mohamed A. Gouda

Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010013

N/A

0.617DataRank · unranked

22 citations

Shaun O’Brien, Rahul A. Sheth, David S. Hong, Aung Naing, Xiao–Ping Zhang +7 more

BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

npj Precision Oncology(2023)10.1038/s41698-022-00341-0

N/A

0.470DataRank · unranked

22 citations

Jason Roszik, Filip Jankú, David S. Hong, Shumei Kato, Aung Naing +11 more

A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyad158

N/A

0.438DataRank · unranked

10 citations

Apostolia M. Tsimberidou, Xueyao Fu, Siqing Fu, Vivek Subbiah, Anil K. Sood +7 more

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi -NT in Patients with Advanced Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3952

N/A

0.330DataRank · unranked

8 citations

Filip Jankú, Siqing Fu, Ecaterina E. Dumbrava, David S. Hong, Daniel D. Karp +20 more

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer

Cancer(2023)10.1002/cncr.34773

N/A

0.269DataRank · unranked

5 citations

Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina A. Piha‐Paul, Julia Ann Moore +18 more

Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma

npj Precision Oncology(2023)10.1038/s41698-023-00398-5

N/A

0DataRank · unranked

11 citations

Neha K. Reddy, Jason T. Huse, Behrang Amini, Mirella Nardo, Mohamed A. Gouda +3 more

RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study

Molecular Cancer(2024)10.1186/s12943-024-01982-4

N/A

0DataRank · unranked

2 citations

Jason Roszik, Jibran Ahmed, Carmelia Maria Noia Barretto, Mirella Nardo, Erick Campbell +9 more

Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0516

N/A

0DataRank · unranked

20 citations

Jacob J. Adashek, Aakash Akshay Sheth, Vivek Subbiah, Blessie Elizabeth Nelson

The abscopal effect in patients with cancer receiving immunotherapy

Med(2023)10.1016/j.medj.2023.02.003

N/A

0DataRank · unranked

68 citations

Jacob J. Adashek, Steven H. Lin, Vivek Subbiah, Blessie Elizabeth Nelson